Genome Editing Market 2025 Growth Trends, Share - Global Analysis and Forecasts

Genome Editing Market to 2025 - Global Analysis and Forecasts by Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), and other); End User (Biotechnology & Pharmaceutical Companies, CROs, and Academic & Government Research Institutes); and Application (Plant Genetic Engineering, Cell Line Engineering, and Animal Genetic Engineering)

Report Code: TIPHE100000853 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Genome Editing is a type of genetic engineering for making some definite changes in the DNA of an organism or cell. Through genome editing DNA is either inserted, deleted, or modified in a living organism genome. The several technologies used for genome editing are TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), and other.

Government initiatives, funding, increase in the number cancer and infectious disease patients are the major drivers which are likely to propel the growth of genome editing market. Growing pharmaceutical industries across the globe, technological advancements, and rising production of genetically altered crops are likely to add new opportunities for this market in the coming years.

The "Global Genome Editing Market Analysis to 2025" is a specialized and in-depth study of the genome editing industry with a focus on the global market trend. The report aims to provide an overview of global genome editing market with detailed market segmentation by technology, end users, application, and geography. The global genome editing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global genome editing market based on products, technology, application, and end users. It also provides market size and forecast till 2025 for overall genome editing market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key genome editing manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc., Thermo Fisher Scientific Inc., GenScript, Lonza, Horizon Discovery Group PLC, Sangamo Therapeutics, Inc., New England Biolabs, Editas Medicine, and Merck KGaA, Inc. among others.

1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance

2 Key Takeaways

3 Genome Editing Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Genome Editing Market - By Technology
3.2.2 Genome Editing Market - By Application
3.2.3 Genome Editing Market - By End User
3.2.4 Genome Editing Market - By Region
3.2.4.1 By Country
3.3 PEST Analysis
3.3.1 North America - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America- PEST Analysis

4 Genome Editing Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

5 Genome Editing Market Analysis- Global
5.1 Global Genome Editing Market Overview
5.2 Global Genome Editing Market Forecasts and Analysis
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions
5.6 Clinical Trials Analysis

6 Genome Editing Market Revenue and Forecasts to 2025 - Technology
6.1 Overview
6.2 Technology Market Forecasts and Analysis (US$ Mn)
6.3 TALENS Market
6.3.1 Overview
6.3.2 TALENS Market Forecasts and Analysis (US$ Mn)
6.4 CRISPR Market
6.4.1 Overview
6.4.2 CRISPR/Cas9 Market Forecasts and Analysis (US$ Mn)
6.5 Zinc Finger Nucleases (ZFNs) Market
6.5.1 Overview
6.5.2 Zinc Finger Nucleases (ZFNs) Market Forecasts and Analysis (US$ Mn)
6.6 Other Market
6.6.1 Overview
6.6.2 Others Market Forecasts and Analysis (US$ Mn)

7 Genome Editing Market Revenue and Forecasts to 2025 - End Users
7.1 Overview
7.2 End Users Market Forecasts and Analysis (US$ Mn)
7.3 Biotechnology & Pharmaceutical Companies Market
7.3.1 Overview
7.3.2 Biotechnology & Pharmaceutical Companies Market Forecasts and Analysis (US$ Mn)
7.4 Academic & Government Research Institutes Market
7.4.1 Overview
7.4.2 Academic & Government Research Institutes Market Forecasts and Analysis (US$ Mn)
7.5 Contract Research Organizations Market
7.5.1 Overview
7.5.2 Contract Research Organizations Market Forecasts and Analysis (US$ Mn)

8 Genome Editing Market Revenue and Forecasts to 2025 - Application
8.1 Overview
8.2 Application Market Forecasts and Analysis
8.3 Plant Genetic Engineering Market
8.3.1 Overview
8.3.2 Plant Genetic Engineering Market Forecasts and Analysis (US$ Mn)
8.4 Cell Line Engineering Market
8.4.1 Overview
8.4.2 Cell Line Engineering Market Forecasts and Analysis (US$ Mn)
8.5 Animal Genetic Engineering Market
8.5.1 Overview
8.5.2 Animal Genetic Engineering Market Forecasts and Analysis (US$ Mn)

9 North America Genome Editing Market Revenue and Forecasts to 2025 - Geographical Analysis
9.1 North America Genome Editing Market Overview
9.2 North America Genome Editing Market Revenue Forecasts and Analysis (US$ Mn)
9.3 North America Market Forecasts and Analysis - By Technology
9.4 North America Market Forecasts and Analysis - By Application
9.5 North America Market Forecasts and Analysis - By End User
9.6 North America Market Forecasts and Analysis - By Country
9.7 US Market Overview
9.7.1 US Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
9.7.2 US Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.7.3 US Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)
9.8 Canada Market Overview
9.8.1 Canada Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
9.8.2 Canada Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.8.3 Canada Genome Editing Market Revenue Forecasts and Analysis-By End User (US$ Mn)
9.9 Mexico Market Overview
9.9.1 Mexico Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
9.9.2 Mexico Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
9.9.3 Mexico Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)

10 Europe Genome Editing Market Revenue and Forecasts to 2025 - Geographical Analysis
10.1 Europe Genome Editing Market Overview
10.2 Europe Genome Editing Market Revenue Forecasts and Analysis (US$ Mn)
10.3 Europe Market Forecasts and Analysis - By End User
10.4 Europe Market Forecasts and Analysis - By Technology
10.5 Europe Market Forecasts and Analysis - By Application
10.6 Europe Market Forecasts and Analysis - By Country
10.7 UK Market Overview
10.7.1 UK Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
10.7.2 UK Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.7.3 UK Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)
10.8 Germany Market Overview
10.8.1 Germany Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
10.8.2 Germany Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8.3 Germany Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)
10.9 France Market Overview
10.9.1 France Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)
10.9.2 France Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
10.9.3 France Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)

11 Asia Pacific Genome Editing Market Revenue and Forecasts to 2025 - Geographical Analysis
11.1 Asia Pacific Genome Editing Market Overview
11.2 Asia Pacific Genome Editing Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Asia Pacific Market Forecasts and Analysis - By Technology
11.4 Asia Pacific Market Forecasts and Analysis - By Application
11.5 Asia Pacific Market Forecasts and Analysis - By End User
11.6 Asia Pacific Market Forecasts and Analysis - By Country
11.7 Japan Market Overview
11.7.1 Japan Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
11.7.2 Japan Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.7.3 Japan Genome Editing Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.8 China Market Overview
11.8.1 China Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
11.8.2 China Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8.3 China Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)
11.9 India Market Overview
11.9.1 India Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
11.9.2 India Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9.3 India Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)

12 Middle East and Africa (MEA) Genome Editing Market Revenue and Forecasts to 2025 - Geographical Analysis
12.1 Middle East and Africa (MEA) Genome Editing Market Overview
12.2 Middle East and Africa (MEA) Genome Editing Market Revenue Forecasts and Analysis (US$ Mn)
12.3 Middle East and Africa (MEA) Market Forecasts and Analysis - By Technology
12.4 Middle East and Africa (MEA) Market Forecasts and Analysis - By Application
12.5 Middle East and Africa (MEA) Market Forecasts and Analysis - By End User
12.6 Middle East and Africa (MEA) Market Forecasts and Analysis - By Country
12.7 South Africa Market Overview
12.7.1 South Africa Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
12.7.2 South Africa Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.7.3 South Africa Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)
12.8 Saudi Arabia Market Overview
12.8.1 Saudi Arabia Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
12.8.2 Saudi Arabia Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8.3 Saudi Arabia Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)
12.9 UAE Market Overview
12.9.1 UAE Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
12.9.2 UAE Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.9.3 UAE Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)

13 South and Central America Genome Editing Market Revenue and Forecasts to 2025 - Geographical Analysis
13.1 South and Central America Genome Editing Market Overview
13.2 South and Central America Genome Editing Market Revenue Forecasts and Analysis (US$ Mn)
13.3 South and Central America Market Forecasts and Analysis - By Technology
13.4 South and Central America Market Forecasts and Analysis - By Application
13.5 South and Central America Market Forecasts and Analysis - By End User
13.6 South and Central America Market Forecasts and Analysis - By Country
13.7 Brazil Market Overview
13.7.1 Brazil Genome Editing Market Revenue Forecasts and Analysis-By Technology (US$ Mn)
13.7.2 Brazil Genome Editing Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.7.3 Brazil Genome Editing Market Revenue Forecasts and Analysis-By End Users (US$ Mn)

14 Industry Landscape
14.1 Organic Growth Strategies
14.1.1 New Product Launches
14.1.2 Marketing & Promotional Activities
14.2 Inorganic Growth Strategies
14.2.1 Partnerships, Collaborations, and Joint Ventures
14.2.2 Mergers & Acquisitions
14.2.3 Geographic Expansions

15 Genome Editing Market, Key Company Profiles
15.1 Transposagen Biopharmaceuticals, Inc.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Overview
15.1.4 Product Portfolio
15.1.5 Product Pipeline
15.1.6 SWOT Analysis
15.1.7 Key Developments
15.2 Integrated DNA Technologies, Inc.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product Portfolio
15.2.5 Product Pipeline
15.2.6 SWOT Analysis
15.2.7 Key Developments
15.3 Thermo Fisher Scientific Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product Portfolio
15.3.5 Product Pipeline
15.3.6 SWOT Analysis
15.3.7 Key Developments
15.4 GenScript
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product Portfolio
15.4.5 Product Pipeline
15.4.6 SWOT Analysis
15.4.7 Key Developments
15.5 Lonza
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Overview
15.5.4 Product Portfolio
15.5.5 Product Pipeline
15.5.6 SWOT Analysis
15.5.7 Key Developments
15.6 Horizon Discovery Group plc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Overview
15.6.4 Product Portfolio
15.6.5 Product Pipeline
15.6.6 SWOT Analysis
15.6.7 Key Developments
15.7 Sangamo Therapeutics, Inc.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 Product Pipeline
15.7.6 SWOT Analysis
15.7.7 Key Developments
15.8 New England Biolabs
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Overview
15.8.4 Product Portfolio
15.8.5 Product Pipeline
15.8.6 SWOT Analysis
15.8.7 Key Developments
15.9 Editas Medicine
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product Portfolio
15.9.5 Product Pipeline
15.9.6 SWOT Analysis
15.9.7 Key Developments
15.10 Merck KGaA
15.10.1Key Facts
15.10.2Business Description
15.10.3Financial Overview
15.10.4Product Portfolio
15.10.5Product Pipeline
15.10.6SWOT Analysis
15.10.7Key Developments

16 Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
Research Methodology
Healthcare
List of Companies

1. Transposagen Biopharmaceuticals, Inc.
2. Integrated DNA Technologies, Inc.
3. Thermo Fisher Scientific Inc.
4. GenScript
5. Lonza
6. Horizon Discovery Group plc
7. Sangamo Therapeutics, Inc.
8. New England Biolabs
9. Editas Medicine
10. Merck KGaA

Select License Type
USD $4550
USD $9100
USD $13650

Free

20%

customization on Pre-Booking
Pre Book